Hazards of Cancer
Increased Cancer Risks In 1994, the FDA approved the sale of Monsanto's controversial GE recombinant Bovine Growth Hormone (rBGH)--injected into dairy cows to force them to produce more milk-- even though scientists warned that significantly higher levels (400-500% or more) of a potent chemical hormone, Insulin-Like Growth Factor (IGF-1), in the milk and dairy products of injected cows, could pose serious hazards for human breast, prostate, and colon cancer. A number of studies have shown that humans with elevated levels of IGF-1 in their bodies are much more likely to get cancer. In addition the US Congressional watchdog agency, the GAO, told the FDA not to approve rBGH, arguing that increased antibiotic residues in the milk of rBGH-injected cows (resulting from higher rates of udder infections requiring antibiotic treatment) posed an unacceptable risk for public health. In 1998, heretofore undisclosed Monsanto/FDA documents were released by government scientists in Canada, showing damage to laboratory rats fed dosages of rBGH. Significant infiltration of rBGH into the prostate of the rats as well as thyroid cysts indicated potential cancer hazards from the drug. Subsequently the government of Canada banned rBGH in early 1999. The European Union has had a ban in place since 1994. Although rBGH continues to be injected into 4-5% of all US dairy cows, no other industrialized country has legalized its use. Even the GATT Codex Alimentarius, a United Nations food standards body, has refused to certify that rBGH is safe.
Information provided with the help of Ronnie Cummins at the Organic Consumers Association